Skip to main content
. Author manuscript; available in PMC: 2014 Sep 30.
Published in final edited form as: NMR Biomed. 2009 Jul;22(6):609–618. doi: 10.1002/nbm.1374

Table 2.

In vivo ROI-based MET2 results for tumor and normal ROIs (as defined in Fig. 1). Component relaxation times (2,n) and signal fractions (pn) were tabulated for each animal using the spectra shown in Fig. 3 (panels c and d). The day post inoculation (DPI) each imaging study was performed is also given for each rat.

Rat
DPI Tumor
Normal
# I
II
p (%) 2 (ms)
pI (%) 2,I (ms) pII (%) 2,II (ms)
1 14 4.5 25.5 95.5 68.1 100 50.7
2 15 4.6 21.2 95.4 85.6 100 44.6
3 16 21.2 28.1 78.8 80.1 100 49.2
4 14 3.0 14.5 97.0 67.4 100 50.3
5 14 8.5 24.3 91.5 70.2 100 49.6
6* 14 0 - 100 83.5 100 48.3
7* 18 0 - 100 80.8 96.8 50.1
8 18 2.0 12.6 98.0 66.2 100 49.6
9 21 3.7 21.9 96.3 85.3 100 49.8
10 18 7.2 17.7 92.8 88.2 96.8 50.1
11* 18 0 - 100 57.2 100 44.2

Mean 16.4±2.4 6.8±6.2 20.7±5.4 93.2±6.2 76.4±9.3 99.4±1.3 48.8±2.3
*

Indicates animals whose tumor T2 spectra exhibited a single peak (n.b., these three animals exhibited relatively small tumors). As a result, spectra from these animals are not given in Fig. 3. For these animals, component values for the single observed peak are given in the long-lived component columns and these values were ignored in calculating the mean component values across animals for tumor results.